Successful bid secures funding for severe asthma treatment
Asthma teams across the South West are encouraged to get involved in creating a common pathway for managing asthma care and improving access to asthma biologic therapy.
New funding available to transform patient lives
A successful bid of £129,000 funding from the NHS Pathway Transformation Fund (PTF), incorporating selected Rapid Uptake Products, has been awarded for the treatment of severe asthma.
The bid collaboration between South West and West of England AHSNs, and the South West Asthma Network, means support is now available to 10 Trusts across the South West of England from Cornwall to Bristol in addition to Bristol Royal Hospital for Children. The two AHSNs will be working alongside the South West Severe Asthma Network, Clinical Commissioning Groups (CCGs) and Acute Trusts to implement the bid objectives
Rapid Uptake Products (RUP) programme identifies products with NICE approval (the National Institute for Health and Care Excellence) which contribute to key clinical priorities, with lower-than-expected uptake. The programme supports the deeper adoption and spread of these proven innovations in the NHS. The Pathway Transformation Fund (PTF) helps support the integration of chosen Rapid Uptake Products into everyday practices to overcome barriers to their use.
Asthma Biologics have been selected as one of the Rapid Uptake Products for 2021/22. These specialist medicines can be made available to treat people with severe asthma who continue to experience asthma attacks despite taking usual treatments.
Asthma biologic therapies can transform the lives of patients with severe asthma through the availability of better treatment options. They help reduce the long-term side effects of traditional asthma treatments and can reduce the frequency of aggravated, life-threatening asthma attacks.
How new funding will be applied
Funding is available for each hospital across the region.
The South West Severe Asthma Network (SWAN) will work with all hospitals to create a common pathway for managing asthma care. The aim is to streamline the referral process to severe asthma centres and improve access to asthma biologic therapy. The SWAN will form a working group involving medical and nursing representatives from each of the Trusts across the South West, supported by a project manager.
This means that each hospital across the region can receive funding to support 2 hours of extra Consultant time and 2 hours extra of Respiratory Nurse time per week to deliver the objectives specified within the bid application.
The bid also allocates funds for enabling Asthma biologic access in children with severe asthma through Bristol Royal Hospital for Children.
We’re encouraging all asthma teams across the South West to get involved in this work, including those that refer patients outside the South West region. For more information please contact the South West AHSN’s RUP lead and Programme Manager Steve Johnson-Wood.